By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



10732 Hawk’s Vista Street

Plantation  Florida  33324  U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Neurotrope Enters Collaborative Agreement With Icahn School Of Medicine At Mount Sinai For Use Of Bryostatin-1 In The Treatment Of Niemann-Pick Disease Type C 7/22/2014 7:09:59 AM
Neurotrope Board Of Directors Appoints Chairmen Ramat And Freiman As Interim Co-CEOs 7/18/2014 11:53:01 AM
Neurotrope Appoints Charles S. Ramat And Paul Freiman As Co-Chairmen Of The Board 6/19/2014 7:41:59 AM
Neurotrope Appoints Neuroscientist Sam Kongsamut As Executive Director, Pharmacology 6/4/2014 7:27:48 AM
Neurotrope Announces Publication Of Positive Human Cell Culture And Mouse Model Data Of Bryostatin 1 5/28/2014 9:12:02 AM
Neurotrope Collaborating With Dr. Paul Wender And Stanford University On Bryostatin Analogues 5/20/2014 10:45:19 AM
Neurotrope Hires Three Experienced Senior Pharmaceutical Executives - A Chief Medical Officer And Heads Of Commercial Operations And Regulatory Affairs 1/28/2014 7:58:18 AM
Neurotrope Appoints James Gottlieb to the Company's Board of Directors 12/16/2013 7:11:53 AM
Neurotrope Appoints Paul E. Freiman to the Company's Board of Directors 10/22/2013 7:33:03 AM
Neurotrope, Announces Dr. Larry D. Altstiel, M.D., Ph.D. Appointed to the Company's Scientific Advisory Board 10/15/2013 8:53:09 AM